MMAA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.643000E-01
Normal-vs-Stage2
8.556600E-01
Normal-vs-Stage3
3.838800E-01
Normal-vs-Stage4
4.911400E-01
Stage1-vs-Stage2
1.339990E-01
Stage1-vs-Stage3
1.589160E-01
Stage1-vs-Stage4
9.155000E-01
Stage2-vs-Stage3
2.203600E-01
Stage2-vs-Stage4
4.721000E-01
Stage3-vs-Stage4
2.037600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.342200E-01
Normal-vs-AfricanAmerican
6.125200E-01
Normal-vs-Asian
7.770000E-01
Caucasian-vs-AfricanAmerican
3.250800E-01
Caucasian-vs-Asian
6.040800E-01
AfricanAmerican-vs-Asian
6.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.684000E-01
Normal-vs-Female
7.171400E-01
Male-vs-Female
1.108850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.719800E-01
Normal-vs-Age(41-60Yrs)
6.065200E-01
Normal-vs-Age(61-80Yrs)
9.617400E-01
Normal-vs-Age(81-100Yrs)
9.288000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.332400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.494800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.877000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.941600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.503200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.189000E-01
Normal-vs-Daily Drinker
9.825800E-01
Normal-vs-Weekly Drinker
9.478000E-01
Normal-vs-Occasional Drinker
7.596800E-01
Normal-vs-Social Drinker
6.829200E-01
Non Drinker-vs-Daily Drinker
6.871200E-01
Non Drinker-vs-Weekly Drinker
8.207800E-01
Non Drinker-vs-Occasional Drinker
2.702800E-01
Non Drinker-vs-Social Drinker
2.592400E-01
Daily Drinker-vs-Weekly Drinker
9.262600E-01
Daily Drinker-vs-Occasional Drinker
5.411000E-01
Daily Drinker-vs-Social Drinker
5.434200E-01
Weekly Drinker-vs-Occasional Drinker
5.485600E-01
Weekly Drinker-vs-Social Drinker
5.495600E-01
Occasional Drinker-vs-Social Drinker
9.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.024560E-01
Normal-vs-Grade 2
1.697840E-02
Normal-vs-Grade 3
1.506270E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.367900E-02
Grade 1-vs-Grade 3
6.814500E-02
Grade 1-vs-Grade 4
1.024560E-01
Grade 2-vs-Grade 3
8.160400E-01
Grade 2-vs-Grade 4
1.697840E-02
Grade 3-vs-Grade 4
1.506270E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.175800E-01
Normal-vs-NonDiabetic
9.448800E-01
Diabetic-vs-NonDiabetic
5.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.694600E-01
Normal-vs-NoPancreatitis
9.963200E-01
Pancreatitis-vs-NoPancreatitis
2.973000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.531400E-01
Normal-vs-N1
8.422800E-01
N0-vs-N1
9.556400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.647200E-01
Normal-vs-TP53-NonMutant
6.963000E-01
TP53-Mutant-vs-TP53-NonMutant
3.655400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
